Lonidamine and Radiotherapy in Head and Neck Cancers

Abstract
The tolerance and antitumor activity of Lonidamine combined with radiotherapy were studied on 40 patients with head and neck cancer and compared with a historical control group. Lonidamine was well tolerated. 26 and 17 complete responses were seen in the Lonidamine-treated group and in the historical control group, respectively.

This publication has 0 references indexed in Scilit: